Relating to permissible accountability interventions for certain school districts with low-performing campuses.
Relating to the inclusion of a school safety domain for evaluating districts and campuses under the public school accountability system.
Relating to the use of glucagon medication on certain public and private school campuses.
Relating to a policy adopted by school districts allowing parent volunteers on school district campuses.
Relating to the administration of opioid antagonists by a school nurse at public school campuses.
Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Relating to an indicator of achievement for evaluating the performance of public elementary, middle, and junior high school campuses and districts under the public school accountability system.
Relating to the administration of opioid antagonists by a school nurse or school district administrative personnel at public school campuses.
Relating to applications for the establishment of certain new open-enrollment charter school campuses.
Relating to the use of prescription glucagon medication on public and private school campuses.